Mesoblast Limited (ASX:MSB)
1.812
+0.087 (5.04%)
May 13, 2025, 3:38 PM AEST
Mesoblast Employees
Mesoblast had 73 employees as of June 30, 2024. The number of employees decreased by 10 or -12.05% compared to the previous year.
Employees
73
Change (1Y)
-10
Growth (1Y)
-12.05%
Revenue / Employee
125.51K AUD
Profits / Employee
-2.29M AUD
Market Cap
2.20B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
CSL Limited | 32,698 |
Cochlear | 5,097 |
Sonic Healthcare | 42,000 |
Ramsay Health Care | 90,000 |
Telix Pharmaceuticals | 234 |
Ansell | 15,000 |
Regis Healthcare | 11,000 |
Neuren Pharmaceuticals | 8 |
Mesoblast News
- 8 days ago - Bullish On Mesoblast: Shifting To Commercial Stage With Ryoncil Approval And Revascor Trials - Seeking Alpha
- 11 days ago - Mesoblast reports Q3 results - Seeking Alpha
- 13 days ago - Appendix 4c Quarterly Activity Report for Quarter Ended March 31, 2025 - GlobeNewsWire
- 14 days ago - Mesoblast Appoints Corporate Finance Leader Lyn Cobley To Board - GlobeNewsWire
- 26 days ago - Mesoblast (MESO) Expands Ryoncil Coverage to 104 Million Insured Lives | MEOBF Stock News - GuruFocus
- 26 days ago - Mesoblast Extends Payer Coverage For Ryoncil® to Over 100 Million US Lives | MESO Stock News - GuruFocus
- 26 days ago - Mesoblast Extends Payer Coverage For Ryoncil® to Over 100 Million US Lives - GlobeNewsWire
- 5 weeks ago - Mesoblast Allogeneic Cell Therapy Products Are Designated 'U.S. Country of Origin' and Not Subject to U.S. Tariffs - Benzinga